Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 9 June 2009, doi:10.1136/bmj.b2340
Cite this as: BMJ 2009;338:b2340
| The first 150 words of the full text of this article appear below. |
The recent NICE guidance on osteoporosis has generated much controversy and the publication of "alternative" guidelines.1 An aspect which has escaped attention is the advice that bone density scanning by dual energy x ray absorptiometry (DEXA) may not be required in women aged
75 who have had a fragility fracture. This has been incorporated into the osteoporosis direct enhanced service agreement for general practitioners, which advises that these patients should be offered preventive treatment with bone sparing drugs without further investigation.
This advice is presumably based on the assumption that most women aged
75 with fragility fractures have osteoporosis. We reviewed the results of DEXA in women aged
75 with fragility fractures who were evaluated by the Lothian and Glasgow fracture liaison services in 2007. The table
shows that only half of them had osteoporosis.
|
Stuart H Ralston, ARC professor of rheumatology1, Gina deLara, osteoporosis specialist nurse1, Donald J Farquhar, consultant geriatrician2, Stephen J Gallacher, consultant physician3, Jim Hannan, consultant medical physicist1, Alastair R McLellan, consultant endocrinologist4
1 Western General Hospital, Edinburgh EH4 2XU, 2 St Johns Hospital, Livingston EH54 6PP, 3 Southern General Hospital, Glasgow G51 4TF, 4 Western Infirmary, Glasgow G11 6NT
Stuart.Ralston@ed.ac.uk
Read all Rapid Responses